The biopharmaceutical industry is a national strategic emerging industry and an important part of the pharmaceutical industry. It has great practical and economic significance. As a century-old school with a long history and outstanding reputation, Nanjing University has cultivated and created many Chinese talents. They have made achievements and achieved outstanding achievements in their respective fields, including "leaders" in the field of biomedicine . Today, let’s get to know 5 of them together and listen to their struggle stories -
(sorted by admission time below)
Xu Yaochang, 1978 Department of Chemistry, Nanjing University
Xu Yaochang graduated from the Department of Chemistry, Nanjing University , and later obtained a doctorate in chemistry from the University of Chicago, USA. Have more than 25 years of experience in new drug research and development and management. He has worked in Eli Lilly, , Novartis , respectively. Later, Shanghai Hansen Biopharmaceutical Technology Co., Ltd. (Hausen Group New Drug R&D Center), led more than 10 innovative drug projects from new drug discovery to clinical stage, spanning multiple disease fields such as tumors, viral infections and mental . He has published more than 50 international patents and a large number of academic papers, and has also served as a judge of many internationally renowned magazines. In April 2016, Xu Yaochang founded Heyu Pharmaceutical and is currently the founder and CEO.
Shanghai Heyu Biopharma Technology Co., Ltd. (Heyu Pharmaceutical) was established in 2016. The company focuses on the research and development of new drugs for small molecule tumor immunity and tumor targeting, and is committed to the development of FIRST-IN-CLASS or BEST-IN-CLASS innovative drugs with novel and high-potential drug targets. In particular, its innovative FGFR4 small molecule oral inhibitor independently developed and owned global intellectual property rights has completed the Phase 41a clinical trial of advanced solid tumors in Taiwan, China, and the Phase 1b clinical trial has been launched in mainland China.
Fu Heliang, Shen Xiaoning, 1979 Department of Chemistry, Nanjing University, 1979 Department of Chemistry, 12
Fu Heliang (left), Shen Xiaoning (right), 15H Heliang, 1979-1989, received a bachelor's degree in the Department of Chemistry, 1 master's degree in organic (chemistry), and a doctoral degree in biochemistry, 1979-1989. He is currently the chairman, general manager and CEO of Jiangsu Aidi Pharmaceutical Co., Ltd.; Shen Xiaoning, an alumnus of the Department of Chemistry, Nanjing University, 1979 Department of Chemistry, 13Harvard University, and currently the deputy general manager and chief scientific officer of Jiangsu Aidi Pharmaceutical Co., Ltd. In addition, Fu Heliang and Shen Xiaoning are also one of the active initiators and participants of the "Nanjing University Gao Jiyu -Dianbang Talent Development Fund".
Eddie Pharmaceutical was founded in 2009. It is a pharmaceutical company dedicated to the research and development, production and sales of products in the fields of diseases that seriously affect human health and life such as antivirals, anti-inflammatory , and anti-tumor. Eddie Pharmaceuticals logged on Science and Technology Innovation Board on July 20, 2020 and was listed on Shanghai Stock Exchange . In June this year, Eddie Pharmaceutical's new Class 1 drug, Enovilin Tablets (also known as ACC007 Tablets), was officially approved, with the indication of treating HIV-1 infection.
Gao Xiang, 1981 Department of Biology, Nanjing University,
Gao Xiang, successively obtained a bachelor's degree in the Department of Biology, Nanjing University, and master's degree in the Department of Biochemistry, and later obtained a doctorate degree from Thomas Jefferson University in the United States. He has conducted postdoctoral research at the world's largest mouse resource center - Jackson Laboratory, USA. After returning to China, he took the lead in presiding over the 15th key project "The Establishment of the National Genetic Engineering Mouse Resource Library". At the end of 2018, the mouse resource library was officially included in the national science and technology resource sharing platform. In 2017, Gao Xiang’s team established Jiangsu Jicui Yaokang Biotechnology Co., Ltd. Gao Xiang is currently a professor at Nanjing University, chairman of Jiangsu Jicui Yaokang Biotechnology Co., Ltd., and director of the National Genetic Engineering Mouse Resource Library.
Jiangsu Jicui Yaokang Biotechnology Co., Ltd. is a high-tech biotechnology enterprise specializing in the research and development of humanized models and drug screening technologies. The company's team has nearly 20 years of experience in the field of model animals, has leading the research and development capabilities of disease models, genetic engineering transformed mouse models, and provides one-stop services such as animal model creation and application development for global scientific research institutions and pharmaceutical companies. It is one of the largest mouse model suppliers in the world.
Cao Lin, 2002 School of Life Sciences, Nanjing University,
Cao Lin, graduated from , Nanjing University School of Life Sciences, National Key Laboratory of Pharmaceutical Biotechnology, National Ministry of Science and Technology "Innovation and Entrepreneurship Talent Promotion Plan" Talent, Jiangsu Province's Six Peak High-level Talents, Jiangsu Province's Third Level Training Target, Jiangsu Province's 333 Project, Jiangsu Province's "Youth Entrepreneurship Talents", Jiangsu Province's Leading New Generation Entrepreneur, Jiangsu Province's Science and Technology Entrepreneur. He has profound attainments in the fields of biochemistry and molecular biology , and breaks the international monopoly in core key technologies and raw materials of biomedicine . In the past two years, it has undertaken more than 10 major projects in provinces and cities, and now it has more than 50 Class II medical device registration certificates and more than 20 authorized patents. In 2012, Cao Lin founded Nanjing Novizan Biotechnology Co., Ltd. and is currently the chairman.
Nowitzan is a biotechnology enterprise that focuses on technical research and development and product development of functional proteins such as enzymes, antigens, antibodies and polymer organic materials. Relying on the independently established key common technology platforms, it has successively entered the business fields of life sciences, in vitro diagnosis, biomedicine, etc. It is one of the few R&D innovative enterprises in China that have both independent and controllable upstream technology development capabilities and terminal product production capabilities. In particular, Novizan's new coronavirus lgM/lgG antibody detection kit (colloidal gold method) has made great contributions during the fight against the new crown epidemic.
From entrepreneurs to experts and scholars, looking at the global biomedicine field, the figures of Nangong people are leaping around. I believe that in the future, more and more young students from Nanyang University will have the mark of "Sincerity, simplicity, and greatness, and encouragement to learn and do our best" , and under the guidance of role models, they will make greater contributions to the scientific cause and the development of the motherland!
Follow the headline account of "South University Admissions Little Blue Whale" to get the latest exciting information about 985, 211, and "Double First-Class" construction of Class A universities - Nanjing University!
Source of this article: Nanjing University Alumni Association , DeepTech Deep Technology, No. 22 Hankou Road Biomedicine (Nanjing University Biomedicine Industry Alumni Association)
